ArticleBMC gastroenterology2024

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.

Noa Krugliak Cleveland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.